Ahmed M Aboshanab

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 6

Top Topics

Molecular Docking

Electronic Health Record

Hepatitis C Virus

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)